Axsome Therapeutics Inc’s recently made public that its Director Saad Mark E unloaded Company’s shares for reported $1.01 million on Sep 11 ’24. In the deal valued at $91.31 per share,11,016 shares were sold. As a result of this transaction, Saad Mark E now holds 10,002 shares worth roughly $0.87 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Saad Mark E bought 11,016 shares, generating $1,005,843 in total proceeds.
Before that, Jacobson Mark L. sold 47,739 shares. Axsome Therapeutics Inc shares valued at $4,022,488 were divested by the Chief Operating Officer at a price of $84.26 per share. As a result of the transaction, Jacobson Mark L. now holds 5,783 shares, worth roughly $0.5 million.
Wells Fargo initiated its Axsome Therapeutics Inc [AXSM] rating to an Overweight in a research note published on September 03, 2024; the price target was $140. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in early August from “a Neutral” to “a Buy”. Needham began covering AXSM with “Buy” recommendation on July 22, 2024. Morgan Stanley revised its rating on April 29, 2024. It rated AXSM as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of AXSM
On Tuesday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock jump 0.07% to $87.01. Over the last five days, the stock has lost -6.44%. Axsome Therapeutics Inc shares have risen nearly 9.93% since the year began. Nevertheless, the stocks have risen 13.90% over the past one year. While a 52-week high of $105.00 was reached on 11/13/24, a 52-week low of $64.11 was recorded on 06/11/24. SMA at 50 days reached $93.43, while 200 days put it at $83.90.
Levels Of Support And Resistance For AXSM Stock
The 24-hour chart illustrates a support level at 85.74, which if violated will result in even more drops to 84.47. On the upside, there is a resistance level at 87.83. A further resistance level may holdings at 88.65. The Relative Strength Index (RSI) on the 14-day chart is 37.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -5.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.92%. Stochastics %K at 14.13% indicates the stock is a buying.
How much short interest is there in Axsome Therapeutics Inc?
A steep rise in short interest was recorded in Axsome Therapeutics Inc stocks on 2024-11-29, dropping by -0.5 million shares to a total of 7.08 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 7.58 million shares. There was a decline of -7.09%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 19, 2024 when Robert W. Baird began covering the stock and recommended ‘”an Outperform”‘ rating along with a $108 price target.
